Biocryst Pharmaceuticals buy Cantor Fitzgerald
Start price
15.10.25
/
50%
€5.72
Target price
15.10.26
€22.38
Performance (%)
29.20%
Price
20:23
€7.39
Summary
This prediction is currently active. The prediction currently has a performance of 29.20%. This prediction currently runs until 15.10.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -2.648% | -2.648% |
| iShares Core DAX® | 2,29 % | 9,96 % |
| iShares Nasdaq 100 | 4,54 % | 8,79 % |
| iShares Nikkei 225® | 2,81 % | 14,08 % |
| iShares S&P 500 | 3,10 % | 6,85 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target raised by analysts at Cantor Fitzgerald from $24.00 to $26.00. They now have an "overweight" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.44
29.04.25
29.04.25
€17.56
29.04.26
29.04.26
4.17%
20:23
20:23
